Skip to main content
Review article

Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China

Bo LiDepartment of Cardiology, Zibo Central Hospital, Shandong University, No. 10, Sonth Shanghai Road, Zibo, 255000, People's Republic of China. [email protected]Jing YangBinzhou Medical University, No. 346, Guanhai Road, Laishan District, Yantai, 264003, Shandong, People's Republic of ChinaFaming ZhaoDepartment of Infectious Diseases, No. 4 Hospital of Zibo, No. 210, Shan Quan Road, Zibo, 255000, People's Republic of ChinaLili ZhiDepartment of Allergy, Zibo Central Hospital, Shandong University, No. 10, Sonth Shanghai Road, Zibo, 255000, People's Republic of ChinaXiqian WangDepartment of Cardiology, Zibo Central Hospital, Shandong University, No. 10, Sonth Shanghai Road, Zibo, 255000, People's Republic of ChinaLin LiuDepartment of Cardiology, Zibo Central Hospital, Shandong University, No. 10, Sonth Shanghai Road, Zibo, 255000, People's Republic of ChinaZhaohui BiDepartment of Cardiology, Zibo Central Hospital, Shandong University, No. 10, Sonth Shanghai Road, Zibo, 255000, People's Republic of ChinaYunhe ZhaoDepartment of Cardiology, Zibo Central Hospital, Shandong University, No. 10, Sonth Shanghai Road, Zibo, 255000, People's Republic of China. [email protected]
2020en
ABI

Abstract

No abstract available.

Identifiers

Citations and references

Cited by 40 references